Carregant...
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
BACKGROUND: Considering the heavy economic burden of osteoporotic fractures, the limits of healthcare resources, and the recent availability of new anti-osteoporosis drugs, there is continuing interest in economic evaluation studies of osteoporosis management strategies. OBJECTIVES: This study aims...
Guardat en:
| Publicat a: | Pharmacoeconomics |
|---|---|
| Autors principals: | , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7867562/ https://ncbi.nlm.nih.gov/pubmed/33026634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-020-00965-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|